How ERK1/2 activation controls cell proliferation and cell death is subcellular localization the answer?

被引:776
作者
Mebratu, Yohannes [1 ]
Tesfaigzi, Yohannes [1 ]
机构
[1] Lovelace Resp Res Inst, Albuquerque, NM 87108 USA
基金
美国国家卫生研究院;
关键词
MAP kinases; activation; epithelial cells; nuclear translocation; cancer; lung diseases; PROTEIN-KINASE KINASE; CISPLATIN-INDUCED APOPTOSIS; FOXO TRANSCRIPTION FACTORS; SERINE THREONINE KINASE; NF-KAPPA-B; MAP-KINASE; NUCLEAR TRANSLOCATION; SIGNAL-TRANSDUCTION; BH3-ONLY PROTEIN; GROWTH-FACTORS;
D O I
10.4161/cc.8.8.8147
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Extracellular signal-regulated protein kinases 1 and 2 (ERK1/2) are members of the mitogen-activated protein kinase super family that can mediate cell proliferation and apoptosis. The Ras-Raf-MEK-ERK signaling cascade controlling cell proliferation has been well studied but the mechanisms involved in ERK1/2-mediated cell death are largely unknown. This review focuses on recent papers that define ERK1/2 translocation to the nucleus and the proteins involved in the cytosolic retention of activated ERK1/2. Cytosolic retention of ERK1/2 denies access to the transcription factor substrates that are responsible for the mitogenic response. In addition, cytosolic ERK1/2, besides inhibiting survival and proliferative signals in the nucleus, potentiates the catalytic activity of some proapoptotic proteins such as DAP kinase in the cytoplasm. Studies that further define the function of cytosolic ERK1/2 and its cytosolic substrates that enhance cell death will be essential to harness this pathway for developing effective treatments for cancer and chronic inflammatory diseases.
引用
收藏
页码:1168 / 1175
页数:8
相关论文
共 135 条
[61]   Control of MAP kinase signaling to the nucleus [J].
Kondoh, K ;
Torii, S ;
Nishida, E .
CHROMOSOMA, 2005, 114 (02) :86-91
[62]   RAF-1 ACTIVATES MAP KINASE-KINASE [J].
KYRIAKIS, JM ;
APP, H ;
ZHANG, XF ;
BANERJEE, P ;
BRAUTIGAN, DL ;
RAPP, UR ;
AVRUCH, J .
NATURE, 1992, 358 (6385) :417-421
[63]   Inhibition of p38 MAP kinase as a therapeutic strategy [J].
Lee, JC ;
Kumar, S ;
Griswold, DE ;
Underwood, DC ;
Votta, BJ ;
Adams, JL .
IMMUNOPHARMACOLOGY, 2000, 47 (2-3) :185-201
[64]   ERK1/2 mitogen-activated protein kinase selectively mediates IL-13-induced lung inflammation and remodeling in vivo [J].
Lee, PJ ;
Zhang, XC ;
Shan, PY ;
Mail, B ;
Lee, CG ;
Homer, RJ ;
Zhu, Z ;
Rincon, M ;
Mossman, BT ;
Elias, JA .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (01) :163-173
[65]   Sustained activation of Ras/Raf/mitogen-activated protein kinase cascade by the tumor suppressor p53 [J].
Lee, SW ;
Fang, L ;
Igarashi, M ;
Ouchi, T ;
Lu, KP ;
Aaronson, SA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (15) :8302-8305
[66]   GROWTH-FACTORS INDUCE NUCLEAR TRANSLOCATION OF MAP KINASES (P42(MAPK) AND P44(MAPK)) BUT NOT OF THEIR ACTIVATOR MAP KINASE KINASE (P45(MAPKK)) IN FIBROBLASTS [J].
LENORMAND, P ;
SARDET, C ;
PAGES, G ;
LALLEMAIN, G ;
BRUNET, A ;
POUYSSEGUR, J .
JOURNAL OF CELL BIOLOGY, 1993, 122 (05) :1079-1088
[67]   DAP-5, a novel homolog of eukaryotic translation initiation factor 4G isolated as a putative modulator of gamma interferon-induced programmed cell death [J].
LevyStrumpf, N ;
Deiss, LP ;
Berissi, H ;
Kimchi, A .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (03) :1615-1625
[68]   Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein, Bim [J].
Ley, R ;
Balmanno, K ;
Hadfield, K ;
Weston, C ;
Cook, SJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (21) :18811-18816
[69]   Extracellular signal-regulated kinases 1/2 are serum-stimulated "BimEL kinases" that bind to the BH3-only protein BimEL causing its phosphorylation and turnover [J].
Ley, R ;
Ewings, KE ;
Hadfield, K ;
Howes, E ;
Balmanno, K ;
Cook, SJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (10) :8837-8847
[70]   Timeline - RAS oncogenes: the first 30 years [J].
Malumbres, M ;
Barbacid, M .
NATURE REVIEWS CANCER, 2003, 3 (06) :459-465